Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival
Sophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>LAG3</i> (<i>LAG-3</i>, <i>CD223</i>) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Emma Grace Bawden, et al.
Plos One
|
April 5, 2014
Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine
Emily Eva Holmes, Maria Jung, Sebastian Meller, et al.
Pigment Cell & Melanoma Research
|
November 17, 2023
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma
Luka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.
The Journal of Molecular Diagnostics : JMD
|
May 4, 2020
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study
Luka de Vos, Maria Jung, Ruth-Miriam Koerber, et al.
Cancer Immunology, Immunotherapy : CII
|
November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
American Journal of Translational Research
|
February 7, 2024
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk
Thomas Büttner, Romina Zarbl, Philipp Krausewitz, et al.
The American Journal of Pathology
|
January 24, 2021
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer
Yuri Tolkach, Romina Zarbl, Simone Bauer, et al.
Plos One
|
November 1, 2016
DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
Barbara Uhl, Dimo Dietrich, Vittorio Branchi, et al.
Oncotarget
|
September 9, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Müller, Martin Braun, Dimo Dietrich, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival
Sophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>LAG3</i> (<i>LAG-3</i>, <i>CD223</i>) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Emma Grace Bawden, et al.
Plos One
|
April 5, 2014
Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine
Emily Eva Holmes, Maria Jung, Sebastian Meller, et al.
Pigment Cell & Melanoma Research
|
November 17, 2023
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma
Luka de Vos-Hillebrand, Simon Fietz, Philip Hillebrand, et al.
The Journal of Molecular Diagnostics : JMD
|
May 4, 2020
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study
Luka de Vos, Maria Jung, Ruth-Miriam Koerber, et al.
Cancer Immunology, Immunotherapy : CII
|
November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
American Journal of Translational Research
|
February 7, 2024
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk
Thomas Büttner, Romina Zarbl, Philipp Krausewitz, et al.
The American Journal of Pathology
|
January 24, 2021
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer
Yuri Tolkach, Romina Zarbl, Simone Bauer, et al.
Plos One
|
November 1, 2016
DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
Barbara Uhl, Dimo Dietrich, Vittorio Branchi, et al.
Oncotarget
|
September 9, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Müller, Martin Braun, Dimo Dietrich, et al.
Page
of 12